Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish
It’s been over two years since one of the worst product launches of all time – Aduhelm (aducanumab). Praised by…
It’s been over two years since one of the worst product launches of all time – Aduhelm (aducanumab). Praised by…
Today’s podcast is a follow up to our 2018 podcast with Randy Curtis about the Jumpstart intervention. On that podcast…
Hot off the press is a brand spanking new updated 2023 AGS Beers Criteria for Potentially Inappropriate Medication Use in…
In 1990 11% of homeless persons were older than 50. Today half are over age 50. Today we talk with…
Social connections impact our health in profound ways, whether it is the support we receive from family and friends in…
Do we need an RCT to establish the worth of chaplaincy? Einstein once said, “Everything that can be counted does…
Two weeks ago on the GeriPal podcast we talked about why and how to write for the general public. This…
Psychedelics are having a moment. Enthusiasm is brimming. Legalization is moving forward in several states, following the lead of Oregon…
Gabapentin is the 10th most prescribed drug in the United States and use is increasing. In 2002, 1% of adults…
You know when you walk out of a patient’s room and have that sense, “This isn’t going to go well.”…